The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial
dc.authorid | Özaslan, C. | |
dc.contributor.author | Özmen, V. | |
dc.contributor.author | Özbaş, S. | |
dc.contributor.author | Karanlık, H. | |
dc.contributor.author | Müslümanoğlu, M. | |
dc.contributor.author | Iğcı, A. | |
dc.contributor.author | Cantürk, Z. | |
dc.contributor.author | Utkan, Z. | |
dc.date.accessioned | 2024-09-25T20:01:29Z | |
dc.date.available | 2024-09-25T20:01:29Z | |
dc.date.issued | 2019 | |
dc.department | BAİBÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü | en_US |
dc.description | 44th Congress of the European-Society-for-Medical-Oncology (ESMO) -- SEP 27-OCT 01, 2019 - Barcelona, SPAIN | en_US |
dc.description.abstract | The MF07-01 trial is a multicenter randomized study comparing locoregional treatment (LRT) followed by systemic therapy (ST) with ST alone in de novo stage IV breast cancer (BC) patients. The aim of this study is to evaluate the importance of LRT in patients who lived at least 5 years after the diagnosis of de novo Stage IV BC | |
dc.description.sponsorship | European Soc Med Oncol,Japanese Soc Med Oncol | en_US |
dc.description.sponsorship | Turkish Federation of Breast Diseases Societies | en_US |
dc.identifier.issn | 0923-7534 | |
dc.identifier.issn | 1569-8041 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/14148 | |
dc.identifier.volume | 30 | en_US |
dc.identifier.wos | WOS:000491295501127 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.institutionauthor | Özaslan, C. | |
dc.language.iso | en | en_US |
dc.publisher | Oxford Univ Press | en_US |
dc.relation.ispartof | Annals of Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.snmz | YK_20240925 | en_US |
dc.title | The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial | en_US |
dc.type | Conference Object | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- v-özmen.pdf
- Boyut:
- 53.53 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam metin/Full text